--- title: "Apnimed (APMD) news: going concern and IPO" url: "https://aibio.space/companies/apnimed/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "APMD going concern and IPO news: Apnimed prices IPO of 12,000,000 shares at $16.00. Apnimed, Inc. (NASDAQ: APMD), United States." --- APMD Apnimed, Inc. NASDAQ · United States # Apnimed (APMD) news APMD going concern and IPO news Financings · 2026-07-31 ## [Apnimed prices IPO of 12,000,000 shares at $16.00](https://aibio.space/news/apnimed-prices-ipo-12-000-000-shares-16-00/) Apnimed priced 12,000,000 shares at $16.00 for $192,000,000 before fees. The company has no approved drug, a secured term loan, and a going-concern warning in its prospectus. ## Latest Apnimed news 1. 2026-07-10 Financings [Apnimed files for IPO, plans Nasdaq Global Market listing as APMD](https://aibio.space/news/apnimed-files-ipo-plans-nasdaq-global-market-listing-apmd/) Apnimed, Inc. filed a Form S-1 with a preliminary prospectus dated July 10, 2026. The cover leaves the share count and price range blank, and the company has no approved drug yet. ## Apnimed at a glance - **Ticker**: APMD - **Listing**: NASDAQ - **Country**: United States ### Related companies - [Kailera Therapeutics](https://aibio.space/companies/kailera-therapeutics/) NASDAQ: KLRA - [Kymera Therapeutics](https://aibio.space/companies/kymera-therapeutics/) NASDAQ: KYMR - [Voyager Therapeutics](https://aibio.space/companies/voyager-therapeutics/) NASDAQ: VYGR - [AquaBounty Technologies](https://aibio.space/companies/aquabounty-technologies/) NASDAQ: AQB - [MetaVia](https://aibio.space/companies/metavia/) NASDAQ: MTVA - [Scribe Therapeutics](https://aibio.space/companies/scribe-therapeutics/) NASDAQ: SCTX - [Aspira Women's Health](https://aibio.space/companies/aspira-women-s-health/) OTC: AWHL - [Galectin Therapeutics](https://aibio.space/companies/galectin-therapeutics/) NASDAQ: GALT ### Also on NASDAQ - [Exelixis](https://aibio.space/companies/exelixis/) EXEL - [Cumberland Pharmaceuticals](https://aibio.space/companies/cumberland-pharmaceuticals/) CPIX - [REGENXBIO](https://aibio.space/companies/regenxbio/) RGNX - [Pluri](https://aibio.space/companies/pluri/) PLUR - [ORASURE TECHNOLOGIES INC](https://aibio.space/companies/orasure-technologies/) OSUR - [BioMarin Pharmaceutical](https://aibio.space/companies/biomarin-pharmaceutical/) BMRN ## Questions about Apnimed Has Apnimed issued a going-concern warning? Our latest story on this, dated Jul 31, 2026: "Apnimed prices IPO of 12,000,000 shares at $16.00". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/apnimed-prices-ipo-12-000-000-shares-16-00/). When did Apnimed go public? Our latest story on this, dated Jul 31, 2026: "Apnimed prices IPO of 12,000,000 shares at $16.00". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/apnimed-prices-ipo-12-000-000-shares-16-00/). What is the ticker symbol of Apnimed? Apnimed, Inc. trades under the ticker APMD on NASDAQ. Where is Apnimed listed? Apnimed, Inc. is listed on NASDAQ. What is the SEC CIK of Apnimed? The SEC Central Index Key (CIK) for Apnimed, Inc. is 1745648. Its filings are on SEC EDGAR. How many shares does Apnimed have outstanding? 41,630,779 shares as of 2026-09-04, per the cover page of its 10-Q filed 2026-09-08. Which country or territory is Apnimed listed under? Our directory records Apnimed, Inc. under United States. What does Apnimed do? Our directory classifies Apnimed, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Apnimed? The ISIN recorded for Apnimed, Inc. is US03770Y1073. Does aibio.space cover Apnimed? aibio.space lists Apnimed, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Apnimed incorporated? SEC records list its state or country of incorporation as DE. What is the latest Apnimed (APMD) stock news? Our latest story on Apnimed, dated Jul 31, 2026: "Apnimed prices IPO of 12,000,000 shares at $16.00". Apnimed priced 12,000,000 shares at $16.00 for $192,000,000 before fees. The company has no approved drug, a secured term loan, and a going-concern warning in its prospectus. [Source](https://aibio.space/news/apnimed-prices-ipo-12-000-000-shares-16-00/). What is Apnimed's latest stock offering or financing news? Our latest financing story, dated Jul 31, 2026: "Apnimed prices IPO of 12,000,000 shares at $16.00". Apnimed priced 12,000,000 shares at $16.00 for $192,000,000 before fees. The company has no approved drug, a secured term loan, and a going-concern warning in its prospectus. [Source](https://aibio.space/news/apnimed-prices-ipo-12-000-000-shares-16-00/). Who were the underwriters or placement agents on Apnimed's offering? From our story: In April 2026 Apnimed signed a credit agreement for up to $150.0 million of term loans, with HCR OSA SPV, LLC as administrative and collateral agent. [Source](https://aibio.space/news/apnimed-prices-ipo-12-000-000-shares-16-00/). How long will Apnimed's cash last? From our story of Jul 31, 2026: The company has no approved drug, a secured term loan, and a going-concern warning in its prospectus. [Source](https://aibio.space/news/apnimed-prices-ipo-12-000-000-shares-16-00/). ## Investor discussion: Apnimed Members talk about Apnimed (APMD). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Apnimed, newest first. Each line links the filing it comes from. 1. 2026-09-08 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1745648/000119312526385356/apmd-20260630.htm) 2. 2026-07-31 Financings Filed a final prospectus for a securities offering. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/1745648/000119312526328422/apmd_424b4.htm) 3. 2026-07-10 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/1745648/000119312526300909/apni-20260710.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:APMD on TradingView](https://www.tradingview.com/symbols/NASDAQ-APMD/). ## SEC filings and registration - **SEC name**: Apnimed, Inc. - **CIK**: 1745648 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: APMD (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company
Emerging growth company - **Business address**: 39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, 02138 - **Phone**: 617-500-8880 - **Shares outstanding**: 41,630,779 as of 2026-09-04 (10-Q filed 2026-09-08) ### Recent filings (8-K and 6-K are the company's own announcements) - [10-Q](https://www.sec.gov/Archives/edgar/data/1745648/000119312526385356/apmd-20260630.htm) filed 2026-09-08 - [8-K](https://www.sec.gov/Archives/edgar/data/1745648/000119312526385355/apmd-20260908.htm) filed 2026-09-08 - [8-K](https://www.sec.gov/Archives/edgar/data/1745648/000119312526330509/apmd-20260803.htm) filed 2026-08-03 - [S-1](https://www.sec.gov/Archives/edgar/data/1745648/000119312526300909/apni-20260710.htm) filed 2026-07-10 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001745648), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Apnimed, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker APMD, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Apnimed, Inc. - **Ticker**: APMD - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: US03770Y1073 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-APMD/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/apnimed/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Apnimed (APMD) news: going concern and IPO", 2026-10-31, https://aibio.space/companies/apnimed/